Obeda 4mg FlexTouch is used for:

• Type 2 diabetes mellitus: To improve blood sugar control in adults along with diet and exercise.

• Chronic weight management: Semaglutide may be prescribed as part of a reduced-calorie diet and increased physical activity in appropriate adults.

Obeda contains Semaglutide, which activates GLP-1 receptors involved in blood sugar regulation and appetite control.

It increases insulin release when blood sugar is high and reduces glucagon release. It also slows stomach emptying, which can increase fullness and reduce food intake.

Tell your doctor about all medicines, supplements and herbal products you take.

• Insulin or sulfonylureas: May increase the risk of hypoglycaemia.

• Oral medicines: Delayed stomach emptying may affect absorption of some oral medicines.

• Other GLP-1 receptor agonists: Do not combine Obeda with another Semaglutide-containing medicine or GLP-1 receptor agonist unless prescribed.

• Medicines requiring monitoring: Tell your doctor about medicines that require regular monitoring.

• Store Obeda 4mg FlexTouch at 2°C to 8°C.

• Do not freeze.

• Do not use if frozen.

• Protect from light.

• Keep out of reach of children.

• Follow the product packaging for storage after first use.

Use Obeda 4mg FlexTouch exactly as prescribed.

The 4mg/3mL pen is used to deliver 1mg doses. It is injected under the skin once weekly into the abdomen, thigh or upper arm.

The dose may be increased gradually depending on blood sugar control, treatment indication and tolerance.

Common side effects include 

• Nausea 

• vomiting 

• diarrhoea 

• constipation

• abdominal pain 

• decreased appetite 

• headache 

• dizziness.

Serious side effects:

• Severe or persistent abdominal pain

• Severe allergic reactions

• Persistent vomiting or diarrhoea with dehydration

• Gallstones or gallbladder inflammation

• Sudden or worsening changes in vision

• Low blood sugar when used with insulin or sulfonylureas

Seek medical attention if severe or persistent symptoms occur.

• The 4mg on the pen refers to the total Semaglutide content.

• The 4mg/3mL presentation delivers 1mg doses.

• Use Obeda on the same day each week.

• Rotate injection sites.

• Monitor blood sugar as advised when using Obeda for diabetes.

• Stay hydrated if vomiting or diarrhoea occurs.

• Tell your doctor before surgery or deep sedation.

• Never share the pen or needles.